Follow
MARIA J. MONTE
Title
Cited by
Cited by
Year
Bile acids: chemistry, physiology, and pathophysiology
MJ Monte, JJG Marin, A Antelo, J Vazquez-Tato
World journal of gastroenterology: WJG 15 (7), 804, 2009
6512009
Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice
I Uriarte, MG Fernandez-Barrena, MJ Monte, MU Latasa, HCY Chang, ...
Gut 62 (6), 899-910, 2013
2052013
Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta
MA Serrano, D Brites, MG Larena, MJ Monte, MP Bravo, N Oliveira, ...
Journal of hepatology 28 (5), 829-839, 1998
2031998
Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy
M Vallejo, O Briz, MA Serrano, MJ Monte, JJG Marin
Journal of hepatology 44 (6), 1150-1157, 2006
1782006
Bile acids in physiology, pathology and pharmacology
J JG Marin, R IR Macias, O Briz, J M Banales, M J Monte
Current drug metabolism 17 (1), 4-29, 2016
1772016
Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum
S Abu‐Hayyeh, C Ovadia, TM Lieu, DD Jensen, J Chambers, PH Dixon, ...
Hepatology 63 (4), 1287-1298, 2016
1432016
Expression in human trophoblast and choriocarcinoma cell lines, BeWo, Jeg-3 and JAr of genes involved in the hepatobiliary-like excretory function of the placenta
MA Serrano, RIR Macias, O Briz, MJ Monte, AG Blazquez, C Williamson, ...
Placenta 28 (2-3), 107-117, 2007
1372007
SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling
JL García‐Rodríguez, L Barbier‐Torres, S Fernández‐Álvarez, ...
Hepatology 59 (5), 1972-1983, 2014
1222014
Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition
J Vaquero, MJ Monte, M Dominguez, J Muntané, JJG Marin
Biochemical pharmacology 86 (7), 926-939, 2013
1222013
Rutin has intestinal antiinflammatory effects in the CD4+ CD62L+ T cell transfer model of colitis
C Mascaraque, C Aranda, B Ocón, MJ Monte, MD Suárez, A Zarzuelo, ...
Pharmacological research 90, 48-57, 2014
1112014
Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid
MJ Perez, RIR Macias, C Duran, MJ Monte, JM Gonzalez-Buitrago, ...
Journal of hepatology 43 (2), 324-332, 2005
1072005
Molecular bases of drug resistance in hepatocellular carcinoma
JJG Marin, RIR Macias, MJ Monte, MR Romero, M Asensio, ...
Cancers 12 (6), 1663, 2020
1062020
Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta
AG Blazquez, O Briz, MR Romero, R Rosales, MJ Monte, J Vaquero, ...
Molecular pharmacology 81 (2), 273-283, 2012
962012
Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps
MR Ballestero, MJ Monte, O Briz, F Jimenez, F Gonzalez-San Martin, ...
Biochemical pharmacology 72 (6), 729-738, 2006
932006
Inhibition of hepatocytary vesicular transport by cyclosporin A in the rat: relationship with cholestasis and hyperbilirubinemia
ID Roman, MJ Monte, JM Gonzalez‐Buitrago, A Esteller, R Jiménez
Hepatology 12 (1), 83-91, 1990
861990
Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development
E Lozano, L Sanchez-Vicente, MJ Monte, E Herraez, O Briz, JM Banales, ...
Molecular Cancer Research 12 (1), 91-100, 2014
832014
Role of TGR5 (GPBAR1) in liver disease
V Keitel, D Häussinger
Seminars in liver disease 38 (04), 333-339, 2018
822018
Comparison of the effects of bile acids on cell viability and DNA synthesis by rat hepatocytes in primary culture
MC Martinez-Diez, MA Serrano, MJ Monte, JJG Marin
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1500 (2), 153-160, 2000
802000
Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors
MF Dominguez, RIR Macias, I Izco-Basurko, A de la Fuente, MJ Pascual, ...
Journal of Pharmacology and Experimental Therapeutics 297 (3), 1106-1112, 2001
782001
Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease
P Munoz-Garrido, JJG Marin, MJ Perugorria, AD Urribarri, O Erice, E Sáez, ...
Journal of hepatology 63 (4), 952-961, 2015
752015
The system can't perform the operation now. Try again later.
Articles 1–20